-
Mashup Score: 11Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization: - 1 year(s) ago
Abstract Background Acute heart failure (AHF) hospitalization presents an opportunity to optimize pharmacotherapy to improve outcomes. Objectives This study’s aim was to define eligibility for init…
Source: JACC: Heart FailureCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 2Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan: - 1 year(s) ago
Abstract Background Sacubitril/valsartan (Sac/Val) improves left ventricular ejection fraction (LVEF) in heart failure (HF) with reduced ejection fraction regardless of previous treatments. Improve…
Source: JACC: Heart FailureCategories: Expert Picks, Latest HeadlinesTweet-
In this issue of #JACCHF, the authors apply a #MachineLearning algorithm to develop and validate a risk model capable of discriminating those with low, moderate, or likelihood of #LVEF <35% at 12 months. https://t.co/XuSkiropBZ #CardioTwitter (2/4) https://t.co/KgMXz1spNY
-
-
Mashup Score: 0Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis: A Network Meta-Analysis - 1 year(s) ago
Abstract Background Despite hypertrophic cardiomyopathy (HCM) being the most common inherited heart disease and conferring increased risk for heart failure (HF) and sudden cardiac death (SCD), risk…
Source: JACC: Heart FailureCategories: Expert Picks, Latest HeadlinesTweet-
Network meta-analysis supporting the development of multiparametric risk prediction algorithms, including advanced imaging markers additively to conventional risk factors, for refined risk stratification in HCM. Learn more: https://t.co/m6vOLFNtwz #JACCHF #cvImaging #cvHCM https://t.co/j4sP4EcQYc
-
-
Mashup Score: 0The End of Endomyocardial Biopsy?: A Practical Guide for Noninvasive Heart Transplant Rejection Surveillance - 1 year(s) ago
Abstract Noninvasive heart transplant rejection surveillance using gene expression profiling (GEP) to monitor immune activation is widely used among heart transplant programs. With the new developm…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
Wondering how to transition to noninvasive surveillance for rejection after 🫀heart tx at your center? Our state-of-the-art review is now online in @JACCJournals #JACCHF Check it out➡️ https://t.co/eYpBCdi523 https://t.co/vvLO6JS0C0
-
-
Mashup Score: 0Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides: - 1 year(s) ago
Abstract Background Myocardial fibrosis may increase vulnerability to poor prognosis in patients with heart failure (HF), even in those patients exhibiting left ventricular reverse remodeling (LVRR…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
👆👇 Biomarker of myocardial fibrosis predictes #LV Reverse Remodeling & outcomes @JACCJournals @stefanocarugo @KardiologieHH @BartoszHudzik @SeguraCardio @ValleAlfonso @WilfriedMullens @ehj_ed @JBauersachsMD @hvanspall @ACCinTouch @AndrewJSauer https://t.co/6qPXrBHUIg https://t.co/vRcQFlHgIO
-
-
Mashup Score: 4Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization: - 1 year(s) ago
Abstract Background Acute heart failure (AHF) hospitalization presents an opportunity to optimize pharmacotherapy to improve outcomes. Objectives This study’s aim was to define eligibility for init…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
RT @ValleAlfonso: 📥@JACCJournals https://t.co/qdoE6XHGpA
-
-
Mashup Score: 6Elimination of the “Increased Risk” Label Has Not Improved Donor Heart Utilization in the U.S.: - 1 year(s) ago
References1. Volk M.L., Wilk A.R., Wolfe C., Kaul D.R. “The “PHS increased risk” label is associated with nonutilization of hundreds of organs per year”. Transplantation 2017;101:1666-1669. 2. Colvin M., Smith J.M., Hadley N., et al. “OPTN/SRTR 2016 annual data report: heart”. Am J Transplant 2018;18:291-362. 3. Mulvihill M.S., Cox M.L., Bishawi M., et al. “Decline of increased risk donor offers…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
RT @rachkataria: Elimination of the “Increased Risk” Label Has Not Improved Donor Heart Utilization in the U.S. https://t.co/AVbK9Iw18q I…
-
-
Mashup Score: 0Elimination of the “Increased Risk” Label Has Not Improved Donor Heart Utilization in the U.S.: - 1 year(s) ago
References1. Volk M.L., Wilk A.R., Wolfe C., Kaul D.R. “The “PHS increased risk” label is associated with nonutilization of hundreds of organs per year”. Transplantation 2017;101:1666-1669. 2. Colvin M., Smith J.M., Hadley N., et al. “OPTN/SRTR 2016 annual data report: heart”. Am J Transplant 2018;18:291-362. 3. Mulvihill M.S., Cox M.L., Bishawi M., et al. “Decline of increased risk donor offers…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
Elimination of the “Increased Risk” Label Has Not Improved Donor Heart Utilization in the U.S. https://t.co/AVbK9Iw18q Important contribution from @danepaneitz @AsishanaOsho et al; thx for making me a part of it. @MGHHeartHealth @MGHSurgery @JACCJournals @ISHLT https://t.co/fuBllAcCdG
-
-
Mashup Score: 0Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization: - 1 year(s) ago
Abstract Background Acute heart failure (AHF) hospitalization presents an opportunity to optimize pharmacotherapy to improve outcomes. Objectives This study’s aim was to define eligibility for init…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/DuA0Hpn8U3
-
-
Mashup Score: 0Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization: - 1 year(s) ago
Abstract Background Acute heart failure (AHF) hospitalization presents an opportunity to optimize pharmacotherapy to improve outcomes. Objectives This study’s aim was to define eligibility for init…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
The available evidence-based #GDMT are expanding across all spectrums of #HeartFailure This 🇨🇦 study supports broad eligibility for GDMT and novel therapies in a real-world patients with AHF with both #HFrEF and #HFpEF https://t.co/yKDrooPCmh @ShelleyZieroth @JACCJournals https://t.co/PpoM9tgUgd
-
Among a large cohort of Canadian patients admitted to the hospital w/ #HeartFailure decompensation, a sig. proportion are eligible for initiation of disease-modifying pharmacotherapies for Tx of #HFrEF & #HFpEF. https://t.co/d1O3sjn8gH #JACCHF #GDMT #CardioTwitter https://t.co/cjbc1n9yV9